Novo Nordisk rebrands diabetes tablet as Ozempic in US
Go back to Novo Nordisk rebrands diabetes tablet as Ozempic in US| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1152.44 +14.62 (1.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1137.82 | 52 Week High | $88.16 | |||
| Open | $1150.27 | 52 Week Low | $67.88 | |||
| Day High | $1159.75 | P/E | 266.77 | |||
| Day Low | $1138.26 | EPS | $4.32 | |||
| Volume | 1,897,937 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 43.19 +1.48 (3.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $41.71 | 52 Week High | $59.00 | |||
| Open | $41.98 | 52 Week Low | $32.80 | |||
| Day High | $43.44 | P/E | N/A | |||
| Day Low | $41.96 | EPS | $0.00 | |||
| Volume | 12,974,379 | |||||
